Stock Story: AMETEK

Alexander Whight, 04 Feb 2022


 
A high quality industrial company you may never have heard of AMETEK is a US listed, differentiated global industrial conglomerate.

Watch
How will corporates spend their excess cash and what does this mean for investors? Part II

Ian Robertson, 02 Feb 2022

Capital allocation is expected to continue to migrate towards capex, shareholder returns and M&A. Implications from this spend is case-by-case, but it is increasingly important for debt investors to know the capital allocation intentions of their investments and remain active in managing their portfolios to help position to benefit from some of these trends as well as avoid pitfalls of others.

Read
Stock market volatility can be an opportunity for investors in the long term

Mark Riggall, 25 Jan 2022

Financial markets have started the year on a weak note, what’s behind the moves and how are we seeing things?
Interest

Read
Stock Story: Neuren Pharmaceuticals

Kate Power, 12 Jan 2022

A promising new drug therapy for those with Rett Syndrome
In December, Neuren Pharmaceuticals and its partner Acadia Pharmaceuticals announced positive

Read
Month in a Minute: December ’21

Mark Riggall, 12 Jan 2022

Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds.
A wider perspective
Fund returns in December were strong as

Watch
Corporate Demergers

Alexander Whight, 14 Dec 2021

Profiting from Management Spin? Opportunities presented by corporate demergers
Breaking up is hard to do. But that is the journey on

Read

The Benefits of Diversification

Bruce O'Leary, 07 Dec 2021

Read
Month in a Minute: November ’21

Mark Riggall, 06 Dec 2021

Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds.
Omicron the headline, interest rates remain the real story
November

Watch